{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:21:53Z","timestamp":1790043713608,"version":"4.0.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To assess the potential of a radiomics approach of late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) in the diagnosis of cardiac amyloidosis (CA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>This retrospective study included 200 patients with biopsy-proven light-chain (AL) amyloidosis. CA was diagnosed on the basis of systemic amyloidosis confirmed with evidence of cardiac involvement by imaging and clinical biomarkers. A total of 139 patients [54 \u00b1 8 years, 75 (54%) men] in our institution were divided into training cohort [<jats:italic>n<\/jats:italic> = 97, mean age of 53 \u00b1 8 years, 54 (56%) men] and internal validation cohort [<jats:italic>n<\/jats:italic> = 42, mean age: 56 \u00b1 8 years, 21 (50%) men] with a ratio of 7:3, while 61 patients [mean age: 60 \u00b1 9 years, 42 (69%) men] from the other two institutions were enrolled for external validation. Radiomics features were extracted from global (all short-axis images from base-to-apex) left ventricular (LV) myocardium and three different segments (basal, midventricular, and apex) on short-axis LGE images using the phase-sensitive reconstruction (PSIR) sequence. The Boruta algorithm was used to select the radiomics features. This model was built using the XGBoost algorithm. The two readers performed qualitative and semiquantitative assessment of the LGE images based on the visual LGE patterns, while the quantitative assessment was measured using a dedicated semi-automatic CMR software. The diagnostic performance of the radiomics and other qualitative and quantitative parameters were compared by a receiver operating characteristic (ROC) curve analysis. A correlation between radiomics and the degree of myocardial involvement by amyloidosis was tested.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1,906 radiomics features were extracted for each LV section. No statistical significance was indicated between any two slices for diagnosing CA, and the highest area under the curve (AUC) was found in basal section {0.92 [95% confidence interval (CI), 0.86\u20130.97] in the LGE images in the training set, 0.89 (95% CI, 0.79\u20131.00) in the internal validation set, and 0.92 (95% CI, 0.85\u20130.99) in the external validation set}, which was superior to the visual assessment and quantitative LGE parameters. Moderate correlations between global or basal radiomics scores (Rad-scores) and Mayo stage in all patients were reported (Spearman\u2019s Rho = 0.61, 0.62; all <jats:italic>p<\/jats:italic> &amp;lt; 0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A radiomics analysis of the LGE images provides incremental information compared with the visual assessment and quantitative parameters on CMR to diagnose CA. Radiomics was moderately correlated with the severity of CA. Further studies are needed to assess the prognostic significance of radiomics in patients with CA.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.818957","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T11:39:25Z","timestamp":1648640365000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnosis of Cardiac Amyloidosis Using a Radiomics Approach Applied to Late Gadolinium-Enhanced Cardiac Magnetic Resonance Images: A Retrospective, Multicohort, Diagnostic Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Xi Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Xiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Kun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Wei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Cui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Zhou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui Sheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Jiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1161\/CIRCULATIONAHA.111.069195","article-title":"Cardiac amyloidosis.","volume":"126","author":"Quarta","year":"2012","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.jcmg.2019.06.023","article-title":"Myocardial amyloidosis: the exemplar interstitial disease.","volume":"12","author":"Fontana","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis.","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00392-020-01799-3","article-title":"Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).","volume":"110","author":"Yilmaz","year":"2021","journal-title":"Clin Res Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jjcc.2017.10.003","article-title":"Recent advances in diagnosis and treatment of cardiac amyloidosis.","volume":"71","author":"Izumiya","year":"2018","journal-title":"J Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cjca.2019.09.017","article-title":"Challenges and strategies in the diagnosis of cardiac amyloidosis.","volume":"36","author":"Fine","year":"2020","journal-title":"Can J Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) cardiac amyloidosis: a review of diagnosis and therapy.","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18f-florbetaben PET: a pilot study.","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc Imaging."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis.","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/ehf2.12511","article-title":"Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.","volume":"6","author":"Brownrigg","year":"2019","journal-title":"ESC Heart Fail."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-017-0419-6","article-title":"The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.","volume":"20","author":"Lin","year":"2018","journal-title":"J Cardiovasc Magn Reson."},{"key":"B13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tcm.2018.06.011","article-title":"Cardiovascular magnetic resonance imaging for amyloidosis: the state-of-the-art.","volume":"29","author":"Tang","year":"2019","journal-title":"Trends Cardiovasc Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis.","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation."},{"key":"B15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis.","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ehjci\/jeaa028","article-title":"Cardiac magnetic resonance radiomics: basic principles and clinical perspectives.","volume":"21","author":"Raisi-Estabragh","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejrad.2018.03.013","article-title":"Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.","volume":"102","author":"Baessler","year":"2018","journal-title":"Eur J Radiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.jcmg.2018.11.024","article-title":"radiomic analysis of myocardial native T1 imaging discriminates between hypertensive heart disease and hypertrophic cardiomyopathy.","volume":"12","author":"Neisius","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1148\/radiol.2018180411","article-title":"Cardiac MRI texture analysis of T1 and T2 maps in patients with infarctlike acute myocarditis.","volume":"289","author":"Baessler","year":"2018","journal-title":"Radiology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1148\/radiol.2017170213","article-title":"Subacute and chronic left ventricular myocardial scar: accuracy of texture analysis on nonenhanced cine MR images.","volume":"286","author":"Baessler","year":"2018","journal-title":"Radiology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12350-019-01761-5","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2-Diagnostic criteria and appropriate utilization.","volume":"27","author":"Dorbala","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases.","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging."},{"key":"B25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1148\/rg.2020190069","article-title":"Trends in diagnostic imaging of cardiac amyloidosis: emerging knowledge and concepts.","volume":"40","author":"Oda","year":"2020","journal-title":"Radiographics."},{"key":"B26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00392-020-01771-1","article-title":"Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.","volume":"110","author":"Chatzantonis","year":"2021","journal-title":"Clin Res Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis.","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging."},{"key":"B28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jcmg.2012.09.018","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.","volume":"6","author":"Moravsky","year":"2013","journal-title":"JACC Cardiovasc Imaging."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jcmg.2018.07.007","article-title":"Relative left ventricular apical sparing of longitudinal strain in cardiac amyloidosis: is it just amyloid infiltration?","volume":"12","author":"Rapezzi","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jcmg.2017.06.020","article-title":"Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality.","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-017-0376-0","article-title":"Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.","volume":"19","author":"Williams","year":"2017","journal-title":"J Cardiovasc Magn Reson."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcmg.2016.01.036","article-title":"Prognostic value of late gadolinium enhancement CMR in systemic amyloidosis.","volume":"9","author":"Raina","year":"2016","journal-title":"JACC Cardiovasc Imaging."},{"key":"B33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jcmg.2015.10.027","article-title":"LGE provides incremental prognostic information over serum biomarkers in AL cardiac amyloidosis.","volume":"9","author":"Boynton","year":"2016","journal-title":"JACC Cardiovasc Imaging."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.818957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T11:39:27Z","timestamp":1648640367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.818957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":33,"alternative-id":["10.3389\/fcvm.2022.818957"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.818957","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"article-number":"818957"}}